【24h】

Outcomes Associated With Bilateral Internal Thoracic Artery Grafting: The Importance of Age

机译:与双侧内部胸动脉嫁接相关的结果:年龄的重要性

获取原文
           

摘要

Data Sources and Study CohortClinical and Outcome VariablesStatistical AnalysisResultsStudy PopulationBaseline Clinical CharacteristicsSurvival and Postoperative RevascularizationAlthough bilateral internal thoracic artery (BITA) grafting in coronary artery bypass grafting (CABG) is associated with low morbidity and good long-term results, controversy exists about the age after which BITA grafting is no longer beneficial. We sought to determine if such an age cutoff point exists.MethodsThe study cohort consisted of 5,601 consecutive patients from a cardiac surgery registry who underwent isolated CABG (1,038 [19%] BITA grafts, 4,029 [72%] single internal thoracic artery [SITA] grafts, 534 [10%] vein-only grafts) between 1995 and 2008. A Cox model was used to compare survival by use of bilateral, single, or no internal thoracic artery (ITA) grafts, adjusting for baseline clinical and demographic characteristics.ResultsMean follow-up was 7.1 years. Patients undergoing BITA grafting had the lowest 1-year mortality (2.4% versus 4.3% SITA grafting and 8.2% vein-only grafting; p < 0.0001). Relative to SITA grafting, a crude survival benefit of 54% existed for BITA grafting (hazard ratio [HR] 0.46; 95% confidence interval [CI], 0.37 to 0.57; p < 0.0001) with worse survival for vein-only grafts (HR, 1.16; 95% CI, 0.99 to 1.37; p = 0.07). After adjustment, the benefit of BITA grafting was no longer statistically significant (HR, 0.87; 95% CI, 0.69 to 1.08; p = 0.2). However age may be an effect modifier: a spline analysis plotting HR (BITA grafting versus SITA grafting) against age suggested a potential survival advantage associated with BITA grafting in patients younger than 69.9 years.ConclusionsBilateral internal thoracic artery grafting is a reasonable revascularization strategy in suitable patients up to age 70 years. As benefits of arterial grafting become more obvious over time, a longer period of follow-up will be needed to confirm the advantage of a BITA grafting strategy. In the meantime the BITA grafting advantage for patients older than 70 years is not clear.CTSNet classification:23Approximately 1 million patients worldwide undergo coronary artery bypass grafting (CABG) every year [
机译:数据来源和研究官方和结果变形统计学分析术临床特征患者患者患者和术后血管内血管内化术冠状动脉旁路接枝(CABG)的双侧内部胸部动脉(BITA)接枝与低发病率和良好的长期结果相关,存在关于年龄的争议比特嫁接不再有益。我们试图确定是否存在这样的年龄截止点。方法中的研究队列由5,601名连续患者组成,该患者来自孤立的CABG的心脏手术登记处(1,038 [19 %] Bita移植物,4,029 [72 %]单内部胸部1995年和2008年之间的动脉[SITA]移植物,534 [10 %]静脉移植物)用于通过使用双侧,单一或没有内部胸腔动脉(ITA)移植物来比较生存,调整基线临床和人口统计学特征。详细的后续行动为7.1年。接受比特嫁接的患者具有最低的1年死亡率(2.4 %对4.3 %sita嫁接和8.2 %静脉嫁接; p <0.0001)。相对于SITA接枝,Bita接枝存在54℃的粗产存益(危害比[HR] 0.46; 95℃,0.37至0.57; p <0.0001),静脉的存活率更差只有移植物(HR,1.16; 95℃,0.99至1.37; P = 0.07)。调整后,比特嫁接的益处不再有统计学意义(HR,0.87; 95℃,0.69至1.08; p = 0.2)。然而,年龄可能是一种效果改性剂:绘制HR(比特嫁接与SITA接枝)对年龄的样条分析表明,与比目前69.9岁的患者的比特嫁接相关的潜在存活优势。合理的内部胸腔动脉嫁接是合理的血运重建策略患者70岁。随着动脉嫁接的益处随着时间的推移而变得更加明显,将需要更长的后续行动来确认比特拉接枝策略的优势。同时,70岁患者的比特嫁接优势不是明确的.CTSNET分类:23万次,全球100万患者每年接受冠状动脉旁路嫁接(CABG)[

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号